1 Market Overview

1.1 Product Overview and Scope of Recombinant DNA (rDNA) Technology

1.2 Classification of Recombinant DNA (rDNA) Technology by Type

1.2.1 Overview: Global Recombinant DNA (rDNA) Technology Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type in 2020

1.2.3 Expression System

1.2.4 Cloning Vector

1.3 Global Recombinant DNA (rDNA) Technology Market by Application

1.3.1 Overview: Global Recombinant DNA (rDNA) Technology Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Biotechnology and Pharmaceutical Companies

1.3.3 Academic and Government Research Institutes

1.3.4 Other

1.4 Global Recombinant DNA (rDNA) Technology Market Size & Forecast

1.5 Global Recombinant DNA (rDNA) Technology Market Size and Forecast by Region

1.5.1 Global Recombinant DNA (rDNA) Technology Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Recombinant DNA (rDNA) Technology Market Size by Region, (2016-2021)

1.5.3 North America Recombinant DNA (rDNA) Technology Market Size and Prospect (2016-2026)

1.5.4 Europe Recombinant DNA (rDNA) Technology Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size and Prospect (2016-2026)

1.5.6 South America Recombinant DNA (rDNA) Technology Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Recombinant DNA (rDNA) Technology Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Recombinant DNA (rDNA) Technology Market Drivers

1.6.2 Recombinant DNA (rDNA) Technology Market Restraints

1.6.3 Recombinant DNA (rDNA) Technology Trends Analysis

2 Company Profiles

2.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)

2.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Details

2.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Major Business

2.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product and Solutions

2.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Developments and Future Plans

2.2 Profacgen

2.2.1 Profacgen Details

2.2.2 Profacgen Major Business

2.2.3 Profacgen Recombinant DNA (rDNA) Technology Product and Solutions

2.2.4 Profacgen Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Profacgen Recent Developments and Future Plans

2.3 Amgen Inc

2.3.1 Amgen Inc Details

2.3.2 Amgen Inc Major Business

2.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Product and Solutions

2.3.4 Amgen Inc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Amgen Inc Recent Developments and Future Plans

2.4 Novartis AG

2.4.1 Novartis AG Details

2.4.2 Novartis AG Major Business

2.4.3 Novartis AG Recombinant DNA (rDNA) Technology Product and Solutions

2.4.4 Novartis AG Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novartis AG Recent Developments and Future Plans

2.5 GenScript

2.5.1 GenScript Details

2.5.2 GenScript Major Business

2.5.3 GenScript Recombinant DNA (rDNA) Technology Product and Solutions

2.5.4 GenScript Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 GenScript Recent Developments and Future Plans

2.6 Pfizer Inc

2.6.1 Pfizer Inc Details

2.6.2 Pfizer Inc Major Business

2.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Product and Solutions

2.6.4 Pfizer Inc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Inc Recent Developments and Future Plans

2.7 Novo Nordisk A/S

2.7.1 Novo Nordisk A/S Details

2.7.2 Novo Nordisk A/S Major Business

2.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product and Solutions

2.7.4 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Novo Nordisk A/S Recent Developments and Future Plans

2.8 Eli Lilly and Company

2.8.1 Eli Lilly and Company Details

2.8.2 Eli Lilly and Company Major Business

2.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Product and Solutions

2.8.4 Eli Lilly and Company Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Eli Lilly and Company Recent Developments and Future Plans

2.9 Sanofi

2.9.1 Sanofi Details

2.9.2 Sanofi Major Business

2.9.3 Sanofi Recombinant DNA (rDNA) Technology Product and Solutions

2.9.4 Sanofi Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Sanofi Recent Developments and Future Plans

2.10 Biocon

2.10.1 Biocon Details

2.10.2 Biocon Major Business

2.10.3 Biocon Recombinant DNA (rDNA) Technology Product and Solutions

2.10.4 Biocon Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Biocon Recent Developments and Future Plans

2.11 GlaxoSmithKline plc

2.11.1 GlaxoSmithKline plc Details

2.11.2 GlaxoSmithKline plc Major Business

2.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product and Solutions

2.11.4 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.12 New England Biolabs.

2.12.1 New England Biolabs. Details

2.12.2 New England Biolabs. Major Business

2.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Product and Solutions

2.12.4 New England Biolabs. Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 New England Biolabs. Recent Developments and Future Plans

2.13 Cibus

2.13.1 Cibus Details

2.13.2 Cibus Major Business

2.13.3 Cibus Recombinant DNA (rDNA) Technology Product and Solutions

2.13.4 Cibus Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Cibus Recent Developments and Future Plans

2.14 Monsanto Company

2.14.1 Monsanto Company Details

2.14.2 Monsanto Company Major Business

2.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Product and Solutions

2.14.4 Monsanto Company Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Monsanto Company Recent Developments and Future Plans

2.15 Horizon Discovery Group PLC

2.15.1 Horizon Discovery Group PLC Details

2.15.2 Horizon Discovery Group PLC Major Business

2.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product and Solutions

2.15.4 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Horizon Discovery Group PLC Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Recombinant DNA (rDNA) Technology Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Recombinant DNA (rDNA) Technology Players Market Share

3.2.2 Top 10 Recombinant DNA (rDNA) Technology Players Market Share

3.2.3 Market Competition Trend

3.3 Recombinant DNA (rDNA) Technology Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Recombinant DNA (rDNA) Technology Revenue and Market Share by Type (2016-2021)

4.2 Global Recombinant DNA (rDNA) Technology Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2016-2021)

5.2 Recombinant DNA (rDNA) Technology Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Recombinant DNA (rDNA) Technology Revenue by Type (2016-2026)

6.2 North America Recombinant DNA (rDNA) Technology Revenue by Application (2016-2026)

6.3 North America Recombinant DNA (rDNA) Technology Market Size by Country

6.3.1 North America Recombinant DNA (rDNA) Technology Revenue by Country (2016-2026)

6.3.2 United States Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

6.3.3 Canada Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

6.3.4 Mexico Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Recombinant DNA (rDNA) Technology Revenue by Type (2016-2026)

7.2 Europe Recombinant DNA (rDNA) Technology Revenue by Application (2016-2026)

7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Country

7.3.1 Europe Recombinant DNA (rDNA) Technology Revenue by Country (2016-2026)

7.3.2 Germany Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

7.3.3 France Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

7.3.5 Russia Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

7.3.6 Italy Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Type (2016-2026)

8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Application (2016-2026)

8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region

8.3.1 Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Region (2016-2026)

8.3.2 China Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8.3.3 Japan Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8.3.4 South Korea Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8.3.5 India Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

8.3.7 Australia Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Recombinant DNA (rDNA) Technology Revenue by Type (2016-2026)

9.2 South America Recombinant DNA (rDNA) Technology Revenue by Application (2016-2026)

9.3 South America Recombinant DNA (rDNA) Technology Market Size by Country

9.3.1 South America Recombinant DNA (rDNA) Technology Revenue by Country (2016-2026)

9.3.2 Brazil Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

9.3.3 Argentina Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Type (2016-2026)

10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Application (2016-2026)

10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country

10.3.1 Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Country (2016-2026)

10.3.2 Turkey Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

10.3.4 UAE Recombinant DNA (rDNA) Technology Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Recombinant DNA (rDNA) Technology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Recombinant DNA (rDNA) Technology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Recombinant DNA (rDNA) Technology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) by Region (2016-2021)

Table 5. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Region (2021-2026)

Table 6. F. Hoffmann-La Roche Ltd (Genentech, Inc) Corporate Information, Head Office, and Major Competitors

Table 7. F. Hoffmann-La Roche Ltd (Genentech, Inc) Major Business

Table 8. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product and Solutions

Table 9. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Profacgen Corporate Information, Head Office, and Major Competitors

Table 11. Profacgen Major Business

Table 12. Profacgen Recombinant DNA (rDNA) Technology Product and Solutions

Table 13. Profacgen Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Amgen Inc Corporate Information, Head Office, and Major Competitors

Table 15. Amgen Inc Major Business

Table 16. Amgen Inc Recombinant DNA (rDNA) Technology Product and Solutions

Table 17. Amgen Inc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 19. Novartis AG Major Business

Table 20. Novartis AG Recombinant DNA (rDNA) Technology Product and Solutions

Table 21. Novartis AG Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. GenScript Corporate Information, Head Office, and Major Competitors

Table 23. GenScript Major Business

Table 24. GenScript Recombinant DNA (rDNA) Technology Product and Solutions

Table 25. GenScript Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Inc Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Inc Major Business

Table 28. Pfizer Inc Recombinant DNA (rDNA) Technology Product and Solutions

Table 29. Pfizer Inc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Novo Nordisk A/S Corporate Information, Head Office, and Major Competitors

Table 31. Novo Nordisk A/S Major Business

Table 32. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product and Solutions

Table 33. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 35. Eli Lilly and Company Major Business

Table 36. Eli Lilly and Company Recombinant DNA (rDNA) Technology Product and Solutions

Table 37. Eli Lilly and Company Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Sanofi Corporate Information, Head Office, and Major Competitors

Table 39. Sanofi Major Business

Table 40. Sanofi Recombinant DNA (rDNA) Technology Product and Solutions

Table 41. Sanofi Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Biocon Corporate Information, Head Office, and Major Competitors

Table 43. Biocon Major Business

Table 44. Biocon Recombinant DNA (rDNA) Technology Product and Solutions

Table 45. Biocon Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 47. GlaxoSmithKline plc Major Business

Table 48. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product and Solutions

Table 49. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. New England Biolabs. Corporate Information, Head Office, and Major Competitors

Table 51. New England Biolabs. Major Business

Table 52. New England Biolabs. Recombinant DNA (rDNA) Technology Product and Solutions

Table 53. New England Biolabs. Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Cibus Corporate Information, Head Office, and Major Competitors

Table 55. Cibus Major Business

Table 56. Cibus Recombinant DNA (rDNA) Technology Product and Solutions

Table 57. Cibus Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Monsanto Company Corporate Information, Head Office, and Major Competitors

Table 59. Monsanto Company Major Business

Table 60. Monsanto Company Recombinant DNA (rDNA) Technology Product and Solutions

Table 61. Monsanto Company Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Horizon Discovery Group PLC Corporate Information, Head Office, and Major Competitors

Table 63. Horizon Discovery Group PLC Major Business

Table 64. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product and Solutions

Table 65. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) by Players (2019-2021)

Table 67. Global Recombinant DNA (rDNA) Technology Revenue Share by Players (2019-2021)

Table 68. Breakdown of Recombinant DNA (rDNA) Technology by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Recombinant DNA (rDNA) Technology Players Head Office, Products and Services Provided

Table 70. Recombinant DNA (rDNA) Technology Mergers & Acquisitions in the Past Five Years

Table 71. Recombinant DNA (rDNA) Technology New Entrants and Expansion Plans

Table 72. Global Recombinant DNA (rDNA) Technology Revenue (USD Million) by Type (2016-2021)

Table 73. Global Recombinant DNA (rDNA) Technology Revenue Share by Type (2016-2021)

Table 74. Global Recombinant DNA (rDNA) Technology Revenue Forecast by Type (2021-2026)

Table 75. Global Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021)

Table 76. Global Recombinant DNA (rDNA) Technology Revenue Forecast by Application (2021-2026)

Table 77. North America Recombinant DNA (rDNA) Technology Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Recombinant DNA (rDNA) Technology Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Recombinant DNA (rDNA) Technology Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Recombinant DNA (rDNA) Technology Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Recombinant DNA (rDNA) Technology Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Recombinant DNA (rDNA) Technology Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Recombinant DNA (rDNA) Technology Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Recombinant DNA (rDNA) Technology Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Recombinant DNA (rDNA) Technology Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Recombinant DNA (rDNA) Technology Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Recombinant DNA (rDNA) Technology Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Recombinant DNA (rDNA) Technology Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Recombinant DNA (rDNA) Technology Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Recombinant DNA (rDNA) Technology Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Recombinant DNA (rDNA) Technology Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Recombinant DNA (rDNA) Technology Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Recombinant DNA (rDNA) Technology Picture

Figure 2. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type in 2020

Figure 3. Expression System

Figure 4. Cloning Vector

Figure 5. Recombinant DNA (rDNA) Technology Revenue Market Share by Application in 2020

Figure 6. Biotechnology and Pharmaceutical Companies Picture

Figure 7. Academic and Government Research Institutes Picture

Figure 8. Other Picture

Figure 9. Global Recombinant DNA (rDNA) Technology Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Recombinant DNA (rDNA) Technology Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Region (2016-2026)

Figure 12. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Region in 2020

Figure 13. North America Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Recombinant DNA (rDNA) Technology Market Drivers

Figure 19. Recombinant DNA (rDNA) Technology Market Restraints

Figure 20. Recombinant DNA (rDNA) Technology Market Trends

Figure 21. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Developments and Future Plans

Figure 22. Profacgen Recent Developments and Future Plans

Figure 23. Amgen Inc Recent Developments and Future Plans

Figure 24. Novartis AG Recent Developments and Future Plans

Figure 25. GenScript Recent Developments and Future Plans

Figure 26. Pfizer Inc Recent Developments and Future Plans

Figure 27. Novo Nordisk A/S Recent Developments and Future Plans

Figure 28. Eli Lilly and Company Recent Developments and Future Plans

Figure 29. Sanofi Recent Developments and Future Plans

Figure 30. Biocon Recent Developments and Future Plans

Figure 31. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 32. New England Biolabs. Recent Developments and Future Plans

Figure 33. Cibus Recent Developments and Future Plans

Figure 34. Monsanto Company Recent Developments and Future Plans

Figure 35. Horizon Discovery Group PLC Recent Developments and Future Plans

Figure 36. Global Recombinant DNA (rDNA) Technology Revenue Share by Players in 2020

Figure 37. Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Recombinant DNA (rDNA) Technology Revenue Market Share in 2020

Figure 39. Global Top 10 Players Recombinant DNA (rDNA) Technology Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Recombinant DNA (rDNA) Technology Revenue Share by Type in 2020

Figure 42. Global Recombinant DNA (rDNA) Technology Market Share Forecast by Type (2021-2026)

Figure 43. Global Recombinant DNA (rDNA) Technology Revenue Share by Application in 2020

Figure 44. Global Recombinant DNA (rDNA) Technology Market Share Forecast by Application (2021-2026)

Figure 45. North America Recombinant DNA (rDNA) Technology Sales Market Share by Type (2016-2026)

Figure 46. North America Recombinant DNA (rDNA) Technology Sales Market Share by Application (2016-2026)

Figure 47. North America Recombinant DNA (rDNA) Technology Revenue Market Share by Country (2016-2026)

Figure 48. United States Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Recombinant DNA (rDNA) Technology Sales Market Share by Type (2016-2026)

Figure 52. Europe Recombinant DNA (rDNA) Technology Sales Market Share by Application (2016-2026)

Figure 53. Europe Recombinant DNA (rDNA) Technology Revenue Market Share by Country (2016-2026)

Figure 54. Germany Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Recombinant DNA (rDNA) Technology Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Recombinant DNA (rDNA) Technology Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Recombinant DNA (rDNA) Technology Revenue Market Share by Region (2016-2026)

Figure 62. China Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Recombinant DNA (rDNA) Technology Sales Market Share by Type (2016-2026)

Figure 69. South America Recombinant DNA (rDNA) Technology Sales Market Share by Application (2016-2026)

Figure 70. South America Recombinant DNA (rDNA) Technology Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Recombinant DNA (rDNA) Technology Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Recombinant DNA (rDNA) Technology Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Recombinant DNA (rDNA) Technology Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Recombinant DNA (rDNA) Technology Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source